Rhythm Pharmaceuticals, Inc. RYTM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

49/100

2/7 Pass

SharesGrow Intrinsic Value

Rhythm Pharmaceuticals, Inc. (RYTM) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は RA CAPITAL MANAGEMENT, LLC 5,422,312 株保有. その他の主要保有者には RA CAPITAL MANAGEMENT, L.P. および THIRD ROCK VENTURES LP.

過去12ヶ月間にインサイダーは 57 件の取引を実施 RYTM 株式 — 19 件の買い (評価額 $3.32M) および 11 件の売り (評価額 $2.56M). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.

RYTM インサイダー保有状況

最大保有者

RA CAPITAL MANAGEMENT, LLC

5,422,312 株

買い（12ヶ月）

$3.32M 評価額

売り（12ヶ月）

$2.56M 評価額

12ヶ月取引活動

買い 33%

売り 19%

インサイダー上位保有者

#	氏名	役職	保有株数	最終申告日	相対規模
1	Ra Capital Management, Llc	10 Percent Owner	5,422,312	2019-10-18	100%
2	Ra Capital Management, L.p.	Officer	4,568,464	2020-12-04	84%
3	Third Rock Ventures Lp	10 Percent Owner	2,981,437	2018-09-04	55%
4	Orbimed Advisors Llc	10 Percent Owner	2,750,079	2018-05-24	51%
5	Foley Todd	Director	909,258	2021-03-16	17%
6	Gottesdiener Keith Michael	CEO & President	207,877	2020-03-11	4%
7	Smith Hunter C	Chief Financial Officer	91,401	2026-03-02	2%
8	Meeker David P	President and CEO	71,900	2026-02-13	1%
9	Desikan Nithya	Chief Commercial Officer	43,602	2020-09-01	1%
10	Fiedorek Fred T.	Chief Medical Officer	25,000	2018-02-16	0%
11	Lee Jennifer Kayden	EVP, Head of North America	21,650	2026-02-13	0%
12	Garfield Alastair	Chief Scientific Officer	16,650	2026-02-13	0%
13	Shulman Joseph	Chief Technical Officer	15,000	2026-02-13	0%
14	Mathers Edward T	Director	14,168	2026-03-16	0%
15	Van Der Ploeg Leonardus H.t.	Chief Scientific Officer	13,611	2019-06-03	0%
16	Manning Linda Shapiro	Chief Medical Officer	12,500	2022-02-11	0%
17	Cramer Pamela J.	Chief Human Resources Officer	11,650	2026-02-13	0%
18	Exter Neil	Director	10,000	2018-06-08	0%
19	Stewart Murray	Chief Medical Officer	9,375	2021-02-16	0%
20	Popovits Kimberly J	Director	6,808	2026-04-03	0%

最近の取引 (過去12ヶ月)

日付	氏名	役職	種類	株数	株価	価値
2026-04-01	Mazabraud Yann	EVP, Head of International	オプション行使（売却）	2,500	-	-
2026-04-01	Popovits Kimberly J	Director	RSU 付与（制限付株式）	6,808	-	-
2026-04-01	Popovits Kimberly J	Director	不明	-	-	-
2026-03-12	Mathers Edward T	Director	その他（買い）	4,199	-	-
2026-03-04	German Christopher Paul	Corporate Controller & CAO	情報に基づく売り	5,614	$89.56	$502.79K
2026-03-02	Mazabraud Yann	EVP, Head of International	RSU 付与（制限付株式）	35,000	$94.94	$3.32M
2026-03-02	Mathers Edward T	Director	その他（買い）	4,198	-	-
2026-03-01	German Christopher Paul	Corporate Controller & CAO	オプション行使（売却）	1,162	-	-
2026-03-02	Smith Hunter C	Chief Financial Officer	オプション行使（売却）	6,099	$6.80	$41.47K
2026-02-19	Smith Hunter C	Chief Financial Officer	情報に基づく売り	585	$103.28	$60.42K
2026-02-17	Smith Hunter C	Chief Financial Officer	情報に基づく売り	200	$103.84	$20.77K
2026-02-14	Mazabraud Yann	EVP, Head of International	オプション行使（売却）	10,000	-	-
2026-02-11	Garfield Alastair	Chief Scientific Officer	RSU 付与（制限付株式）	16,650	-	-
2026-02-11	Shulman Joseph	Chief Technical Officer	RSU 付与（制限付株式）	15,000	-	-
2026-02-11	Cramer Pamela J.	Chief Human Resources Officer	RSU 付与（制限付株式）	11,650	-	-
2026-02-11	Lee Jennifer Kayden	EVP, Head of North America	RSU 付与（制限付株式）	21,650	-	-
2026-02-11	Mazabraud Yann	EVP, Head of International	RSU 付与（制限付株式）	23,350	-	-
2026-02-11	Meeker David P	President and CEO	RSU 付与（制限付株式）	71,900	-	-
2026-02-11	German Christopher Paul	Corporate Controller & CAO	RSU 付与（制限付株式）	5,215	-	-
2026-02-12	Smith Hunter C	Chief Financial Officer	情報に基づく売り	100	$100.10	$10.01K
2026-02-11	Smith Hunter C	Chief Financial Officer	RSU 付与（制限付株式）	25,000	-	-
2026-02-10	Smith Hunter C	Chief Financial Officer	情報に基づく売り	100	$104.76	$10.48K
2026-02-05	Smith Hunter C	Chief Financial Officer	情報に基づく売り	3,381	$106.06	$358.6K
2026-02-04	Smith Hunter C	Chief Financial Officer	情報に基づく売り	747	$107.67	$80.43K
2026-02-01	Garfield Alastair	Chief Scientific Officer	RSU 源泉徴収	2,026	$108.99	$220.81K